Literature DB >> 28759310

Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.

Brent Race1, Martin Jeffrey2, Gillian McGovern2, David Dorward3, Bruce Chesebro1.   

Abstract

In most human and animal prion diseases the abnormal disease-associated prion protein (PrPSc) is deposited as non-amyloid aggregates in CNS, spleen and lymphoid organs. In contrast, in humans and transgenic mice with PrP mutations which cause expression of PrP lacking a glycosylphosphatidylinositol (GPI)-anchor, most PrPSc is in the amyloid form. In transgenic mice expressing only anchorless PrP (tg anchorless), PrPSc is deposited not only in CNS and lymphoid tissues, but also in extraneural tissues including heart, brown fat, white fat, and colon. In the present paper, we report ultrastructural studies of amyloid PrPSc deposition in extraneural tissues of scrapie-infected tg anchorless mice. Amyloid PrPSc fibrils identified by immunogold-labeling were visible at high magnification in interstitial regions and around blood vessels of heart, brown fat, white fat, colon, and lymphoid tissues. PrPSc amyloid was located on and outside the plasma membranes of adipocytes in brown fat and cardiomyocytes, and appeared to invaginate and disrupt the plasma membranes of these cell types, suggesting cellular damage. In contrast, no cellular damage was apparent near PrPSc associated with macrophages in lymphoid tissues and colon, with enteric neuronal ganglion cells in colon or with adipocytes in white fat. PrPSc localized in macrophage phagolysosomes lacked discernable fibrils and might be undergoing degradation. Furthermore, in contrast to wild-type mice expressing GPI-anchored PrP, in lymphoid tissues of tg anchorless mice, PrPSc was not associated with follicular dendritic cells (FDC), and FDC did not display typical prion-associated pathogenic changes.

Entities:  

Keywords:  Alzheimer disease; CAA; amyloid; basement membrane; brown fat; cerebral amyloid angiopathy; colon; follicular dendritic cells; glycosaminoglycan; glycosylphosphatidylinositol; heart; lymphoid tissues; macrophages; prion protein; spleen; transmissible spongiform encephalopathies; white fat

Mesh:

Substances:

Year:  2017        PMID: 28759310      PMCID: PMC5553302          DOI: 10.1080/19336896.2017.1336274

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  32 in total

1.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

2.  Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Rebecca Rosenke; James F Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

4.  Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.

Authors:  Casper Jansen; Piero Parchi; Sabina Capellari; Ad J Vermeij; Patrizia Corrado; Frank Baas; Rosaria Strammiello; Willem A van Gool; John C van Swieten; Annemieke J M Rozemuller
Journal:  Acta Neuropathol       Date:  2009-11-13       Impact factor: 17.088

5.  Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.

Authors:  Bruce Chesebro; Brent Race; Kimberly Meade-White; Rachel Lacasse; Richard Race; Mikael Klingeborn; James Striebel; David Dorward; Gillian McGovern; Martin Jeffrey
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

6.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.

Authors:  B Ghetti; P Piccardo; M G Spillantini; Y Ichimiya; M Porro; F Perini; T Kitamoto; J Tateishi; C Seiler; B Frangione; O Bugiani; G Giaccone; F Prelli; M Goedert; S R Dlouhy; F Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

7.  Determination of the frequency and distribution of vascular and parenchymal amyloid with polyclonal and N-terminal-specific PrP antibodies in scrapie-affected sheep and mice.

Authors:  M Jeffrey; C M Goodsir; A Holliman; R J Higgins; M E Bruce; P A McBride; J R Fraser
Journal:  Vet Rec       Date:  1998-05-16       Impact factor: 2.695

Review 8.  Amyloidosis.

Authors:  Mark B Pepys
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

9.  Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein.

Authors:  Alejandra Rangel; Brent Race; Mikael Klingeborn; James Striebel; Bruce Chesebro
Journal:  Acta Neuropathol Commun       Date:  2013-06-19       Impact factor: 7.801

10.  Scrapie-specific pathology of sheep lymphoid tissues.

Authors:  Gillian McGovern; Martin Jeffrey
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

View more
  1 in total

1.  Formation of distinct prion protein amyloid fibrils under identical experimental conditions.

Authors:  Mantas Ziaunys; Tomas Sneideris; Vytautas Smirnovas
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.